vendredi 18 mai 2018

Onco Actu du 18 mai 2018

1. Biologie

How pancreatic cancer spreads after surgery [Cold Spring Harbor Lab]

3.1.1 Prévention - Tabac - e-cigs

FDA requires additional e-cigarette makers to provide critical information so the agency can better examine youth use and product appeal, amid continued concerns around youth access to products [FDA]

4. Dépistage, diagnostic et pronostic

Breath test breakthrough for early diagnosis of oesophageal and gastric cancer [Imperial College]

4.10 Dép., diag. & prono. - Poumon

A cancer screening flop: Few smokers seek free lung scans [AP]

4.3 Dép., diag. & prono. - Industriels

OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million [Xconomy]

4.9 Dép., diag. & prono. - Sein

Turning 40? You might want to skip this mammography primer from U.S. News [HealthNewsReview]

5.10 Traitements - Essais

NIH: 'If we don't report our results we will repeat mistakes' [Outsourcing Pharma]

5.3 Traitements - FDA, EMA, NICE...

Background Analysis: US FDA Advisory Committee to Review Molecular Targets for Pediatric Cancers and Discuss Approaches to Pediatric Drug Development – JUN 20, 2018 (ODAC) [SAC Tracker]

Who’s delaying generic competition? FDA publishes a long list of drugmakers they say gamed the system [EndPoints]

EMA Adopts ICH Q&A on Nonclinical Evaluation for Cancer Drugs [RAPS]

FDA calls out 39 drug companies for allegedly blocking access to generics [STAT]

How A Drugmaker Gamed The System To Keep Generic Competition Away [NPR]

F.D.A. Names and Shames Drug Makers to Encourage Generic Competition [NY Times]

5.5.1 ASCO (général)

ASCO 2018: Some pearls from the abstracts [David Sampson] ASCO (général) - Industriels

Seattle Genetics Announces Data Presentations at 2018 ASCO Annual Meeting [Seattle Genetics]

Bayer highlights latest oncology research at ASCO 2018 [Bayer]

Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer [Novartis]

Takeda to Highlight Broad Oncology Portfolio and Pipeline Data at the American Society of Clinical Oncology (ASCO) and the Congress of the European Hematology Association (EHA) Annual Meetings [Takeda]

The top winners and losers on ASCO abstract night: Loxo, Blueprint, Jounce, Merck KGaA and more [EndPoints]

6. Lutte contre les cancers

My cancer is in remission – does this mean I’m cured ? [The Conversation]

6.1 Observation

Cancer patients waiting up to 18 months for NHS treatment [The Telegraph]

Cancer patient waited 541 days for NHS treatment, report says [The Guardian]

6.10.1 Politiques (USA)

Right-to-try bill headed for vote puts bigger burden on FDA to protect patients, Gottlieb says [STAT]

Trump’s Drug Pricing Speech Breaks Little New Ground, Largely Spares Industry [Health Affairs]

6.7 DMP, Big Data & applis

Verily Advisory Board series: Linda Avey discusses health data sharing & ownership [Verily]

Your Emergency Contact Information Could Be Used in a Medical Study [NY Times]

Rethinking Academic Data Sharing [Simply Statistics]

6.7.1 IA/bioinformatique

Why are AI researchers boycotting a new Nature journal—and shunning others? [Science]